Vaxxinity Earnings Estimates, EPS & Revenue | OTC:VAXX | Benzinga

Vaxxinity reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Mar 27
EPS
$-0.090
Quarterly Revenue
$0.00
Annual Revenue
(as of Dec 31)

Analyze the earnings history of Vaxxinity using advanced sorting and filters.

Get Alert
VAXXVaxxinity-$0.09$0.0006/20/2025Get Alert
VAXXVaxxinity-$0.16-$0.10-$0.0910.00%$0.00$0.0003/27/2024Get Alert
VAXXVaxxinity-$0.15-$0.12-$0.1016.67%$0.00$0.0011/08/2023Get Alert
VAXXVaxxinity-$0.14-$0.15-$0.1126.67%$0.00$0.0008/09/2023Get Alert
VAXXVaxxinity-$0.15-$0.16-$0.156.25%$0.00$0.0005/09/2023Get Alert
VAXXVaxxinity-$0.48-$0.16-$0.160.00%$0.00$0.0003/27/2023Get Alert
VAXXVaxxinity-$0.44-$0.15-$0.150.00%$50.00K$0.0011/10/2022Get Alert
VAXXVaxxinity-$0.39-$0.49-$0.1471.43%$0.00$0.0008/11/2022Get Alert
VAXXVaxxinity-$0.47-$0.36-$0.1558.33%$17.00K$0.0005/09/2022Get Alert
VAXXVaxxinity-$0.19-$0.36-$0.48-33.33%$0.0003/24/2022Get Alert
VAXXVaxxinity-$0.44$50.00K12/23/2021Get Alert

Vaxxinity (VAXX) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q42024-03-27$-0.09$-0.1010.0 %
Q32023-11-08$-0.10$-0.1216.7 %
Q22023-08-09$-0.11$-0.1526.7 %
Q12023-05-09$-0.15$-0.166.25 %

Vaxxinity (VAXX) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %

FAQ

Q

When is Vaxxinity (OTCEM:VAXX) reporting earnings?

A

Vaxxinity (VAXX) is scheduled to report earnings on June 20, 2025. The last reported earnings were for reported on March 27, 2024 for Q4.

Q

What were the latest earnings per share (EPS) for Vaxxinity (OTCEM:VAXX)?

A

The Actual EPS was $-0.09, which beat the estimate of $-0.10.

Q

What were Vaxxinity’s (OTCEM:VAXX) revenues?

A

The Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.